Search
Find a recruiting study
7,106 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Nov 1, 2026). No sign-up needed.
Most recently updated studies · page 99 of 297
- Recruiting
Reduction or Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)
InnovHeart
- Location
- Thousand Oaks, CA + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Clearwater, FL + 12 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
Novartis Pharmaceuticals
- Location
- Aurora, CO + 4 other US sites
- Eligibility basics
- Ages 12–100
- RecruitingPhase 3
Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia
Pharmacosmos A/S
- Location
- Miami, FL
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Tucson, AZ + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
Novartis Pharmaceuticals
- Location
- Atlanta, GA + 3 other US sites
- Eligibility basics
- Ages 2–18
- RecruitingPhase 1
A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity
AbbVie
- Location
- Anaheim, CA + 1 other US site
- Eligibility basics
- Ages 18–65
- RecruitingPhase 1/Phase 2
A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)
Nuevocor Pte. Ltd.
- Location
- Los Angeles, CA + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
X4 Pharmaceuticals
- Location
- Phoenix, AZ + 20 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
BOOM-IBD2 Pivotal Clinical Trial
Boomerang Medical
- Location
- Folsom, CA + 15 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants
AbbVie
- Location
- Los Angeles, CA + 14 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 2
HB-adMSCs for the Treatment of Crohn's Disease
Hope Biosciences Research Foundation
- Location
- Sugar Land, TX
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
EyeBiotech Ltd.
- Location
- Gilbert, AZ + 51 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 2
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Enveda Therapeutics
- Location
- Encinitas, CA + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Trial of CRD-4730 in HFrEF
Cardurion Pharmaceuticals, Inc.
- Location
- Pasadena, CA + 1 other US site
- Eligibility basics
- Ages 18–85
- RecruitingPhase 3
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Octapharma
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
Renovion, Inc.
- Location
- Los Angeles, CA + 17 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1/Phase 2
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations
Regeneron Pharmaceuticals
- Location
- Los Angeles, CA + 8 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 2
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis
Panafina, Inc.
- Location
- Little Rock, AR + 9 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
CSL Behring
- Location
- Little Rock, AR + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Regeneron Pharmaceuticals
- Location
- Lakewood, CO + 4 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery
Intuitive Surgical
- Location
- Newport Beach, CA + 5 other US sites
- Eligibility basics
- Ages 16–75
- RecruitingPhase 2
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc.
- Location
- Phoenix, AZ + 11 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets.
Neuvosyn Laboratories, LLC
- Location
- Miami, FL + 1 other US site
- Eligibility basics
- Ages 18–75
Data source: daily sync of the ClinicalTrials.gov API. How we list studies